Strategy and Operations Associate, Vial

The problem currently faced by the biotech industry is that clinical trials are slow-moving and capital-intensive. One inefficiency is the specificity required when cherry-picking the right candidates for a drug. Aiding this process, Vial helps companies find patients across any given country and better collect data that can be organized.

With impressive funding at its disposal, one round recently led by General Catalyst, Vial will continue to help simplify an unorganised industry. With investments in this field becoming increasingly active, Vial is well placed to continue its upwards growth.